Personalis, Inc. Lease, Cost
Personalis, Inc. (PSNL) reported Lease, Cost of $1.88 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-04
- Personalis, Inc. lease, cost for the quarter ending 2026-06-30 was $1.88M, a 6.57% decline year-over-year.
- Personalis, Inc. lease, cost for the quarter ending 2026-03-31 was $1.85M, a 0.27% increase year-over-year.
- Personalis, Inc. lease, cost for the quarter ending 2025-12-31 was $1.98M, a 0.05% increase year-over-year.
- Personalis, Inc. lease, cost for the quarter ending 2025-09-30 was $2.00M, a 0.94% decline year-over-year.
- Personalis, Inc. lease, cost for fiscal 2025 was $7.84M, a 5.02% decline from fiscal 2024.
- Personalis, Inc. lease, cost for fiscal 2024 was $8.25M, a 6.41% decline from fiscal 2023.
- Personalis, Inc. lease, cost for fiscal 2023 was $8.82M, a 12.36% decline from fiscal 2022.
- Personalis, Inc. lease, cost for fiscal 2022 was $10.06M, a 54.22% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.88M 10-Q · filed 2026-08-04 | $3.73M 10-Q · filed 2026-08-04 | $5.71M derived: sum of 3 quarters · filed 2026-08-04 | $7.71M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $1.85M 10-Q · filed 2026-05-07 | $3.84M derived: sum of 2 quarters · filed 2026-05-07 | $5.84M derived: sum of 3 quarters · filed 2026-05-07 | $7.84M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.98M derived: sum of 2 quarters · filed 2026-02-26 | $5.99M derived: sum of 3 quarters · filed 2026-08-04 | $7.84M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.00M 10-Q · filed 2025-11-04 | $4.01M derived: sum of 2 quarters · filed 2026-08-04 | $5.86M 10-Q · filed 2025-11-04 | $7.84M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $2.01M 10-Q · filed 2026-08-04 | $3.86M 10-Q · filed 2026-08-04 | $5.84M derived: sum of 3 quarters · filed 2026-08-04 | $7.86M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.85M 10-Q · filed 2026-05-07 | $3.83M derived: sum of 2 quarters · filed 2026-05-07 | $5.85M derived: sum of 3 quarters · filed 2026-05-07 | $8.04M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.00M derived: sum of 2 quarters · filed 2026-02-26 | $6.18M derived: sum of 3 quarters · filed 2026-02-26 | $8.25M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.02M 10-Q · filed 2025-11-04 | $4.20M derived: sum of 2 quarters · filed 2025-11-04 | $6.27M 10-Q · filed 2025-11-04 | $8.39M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $2.19M 10-Q · filed 2025-08-05 | $4.25M 10-Q · filed 2025-08-05 | $6.37M derived: sum of 3 quarters · filed 2025-08-05 | $8.47M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $2.07M 10-Q · filed 2025-05-06 | $4.19M derived: sum of 2 quarters · filed 2025-05-06 | $6.29M derived: sum of 3 quarters · filed 2025-05-06 | $8.55M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.22M derived: sum of 2 quarters · filed 2025-02-27 | $6.48M derived: sum of 3 quarters · filed 2025-02-27 | $8.82M 10-K · filed 2025-02-27 |
| 2023-09-30 | $2.10M 10-Q · filed 2024-11-06 | $4.36M derived: sum of 2 quarters · filed 2024-11-06 | $6.70M 10-Q · filed 2024-11-06 | $9.24M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $2.26M 10-Q · filed 2024-08-07 | $4.60M 10-Q · filed 2024-08-07 | $7.14M derived: sum of 3 quarters · filed 2024-08-07 | $9.63M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $2.34M 10-Q · filed 2024-05-08 | $4.88M derived: sum of 2 quarters · filed 2024-05-08 | $7.37M derived: sum of 3 quarters · filed 2024-05-08 | $9.94M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $5.03M derived: sum of 2 quarters · filed 2024-02-28 | $7.60M derived: sum of 3 quarters · filed 2024-02-28 | $10.06M 10-K · filed 2024-02-28 |
| 2022-09-30 | $2.49M 10-Q · filed 2023-11-07 | $5.05M derived: sum of 2 quarters · filed 2023-11-07 | $7.52M 10-Q · filed 2023-11-07 | $10.10M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $2.57M 10-Q · filed 2023-08-08 | $5.03M 10-Q · filed 2023-08-08 | $7.62M derived: sum of 3 quarters · filed 2024-02-28 | $9.48M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $2.46M 10-Q · filed 2023-05-03 | $5.05M derived: sum of 2 quarters · filed 2024-02-28 | $6.91M derived: sum of 3 quarters · filed 2024-02-28 | $8.04M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $4.45M derived: sum of 2 quarters · filed 2024-02-28 | $5.57M derived: sum of 3 quarters · filed 2024-02-28 | $6.53M 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.86M 10-Q · filed 2022-11-02 | $2.99M derived: sum of 2 quarters · filed 2022-11-02 | $3.94M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $1.13M 10-Q · filed 2022-08-03 | $2.08M 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $951.00K 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $3.27M 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $1.98M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |